These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35851772)

  • 1. Immunohistochemical expression of CK20, CK7, and CDX2 in colorectal carcinoma in correlation with pathomorphological characteristics.
    Ilieva N; Tashkova D; Staykov D; Serteva D; Feodorova Y; Mehterov N; Mollova A; Bachurska S
    Folia Med (Plovdiv); 2022 Apr; 64(2):214-220. PubMed ID: 35851772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
    Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.
    Saad RS; Silverman JF; Khalifa MA; Rowsell C
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):196-201. PubMed ID: 19098678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.
    Lugli A; Tzankov A; Zlobec I; Terracciano LM
    Mod Pathol; 2008 Nov; 21(11):1403-12. PubMed ID: 18587323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
    Landau MS; Kuan SF; Chiosea S; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R; Haltas H; Yenidunya S
    Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles.
    Al-Maghrabi J; Emam E; Gomaa W
    Saudi J Gastroenterol; 2018; 24(2):129-134. PubMed ID: 29637921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of SATB2, CK7 and CK20 in colorectal cancer].
    Lyn J; Wang Y; Wang F; Shen M; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):578-81. PubMed ID: 26705182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
    Tot T
    Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma.
    Sree UD; Prayaga AK; R Reddy VV; Rukmanghadha N; Chowhan AK; Phaneendra BV
    Indian J Pathol Microbiol; 2022; 65(1):42-48. PubMed ID: 35074964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
    Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
    Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers CDX2, CK20, CK7 in Schoolchildren with Gastritis in the Realization of Familial Predisposition of Stomach Cancer.
    Polivanova TV; Kasparov EV; Vshivkov VA; Peretyatko OV
    Bull Exp Biol Med; 2021 Dec; 172(2):187-190. PubMed ID: 34853972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract].
    Yue C; Piao Y; Bai Y; Liu H; Zhang L
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2447-50. PubMed ID: 26711206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM; Meir A; Sabo E
    Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of ampulla of Vater cancer subtype classification based on immunohistochemical staining.
    Kwon CH; Ahn JH; Seo HI; Kim DU; Han SY; Kim S; Lee NK; Hong SB; Park YM; Noh BG
    World J Surg Oncol; 2024 Jan; 22(1):5. PubMed ID: 38167037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of CDX-2, CK7 and CK20 in primary and metastatic ovarian carcinoma].
    Yuan ZF; Shi HR; Sun HM; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):555-6. PubMed ID: 17980105
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroid Transcription Factor-1 Expression in Adenocarcinomas of the Bile Duct.
    Lino-Silva LS; Salcedo-Hernández RA; García-Gómez MA; Ruiz-García EB; Aguilar-Romero JM; Domínguez-Rodríguez JA; Herrera-Gómez Á; Maldonado-Martínez HA
    Int J Surg Pathol; 2016 Feb; 24(1):24-8. PubMed ID: 26316052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
    Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.